Quantum Biopharma Ltd (QNTM) Stock Price, Quote & News

Company Profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is...

Industry: Biotechnology

Sector: Healthcare

Phone: 833 571 1811

Website: www.quantumbiopharma.com

Address:

55 University Avenue, Suite 1003, Toronto, Canada

Regardo7epic Feb. 28 at 8:46 PM

The judge in MMAT receivership asked for proof of loss of business revenue , the legal team came back with 1.3 $$$BILLION in loss from high frequency , short and distort sales of stock. Treble damage is on the table boys. This judge is pro investigating Citadel, Virtu , Anson Funds starting with 161 days of trades over 4 years. I imagine that Wes Christian and Kasowitz will be blowing up this data which also shows what other companies have dealt with. $BINI $GNS $QNTM $GME $DJT Predatory algorithms and stock sold and moved off shore , not reported to SEC is not a good look. OH YAH ….. Jane Street is coughing up data and information that implicates all of these market makers or so called supposed to be market makers. Hahhahahah

1 · Reply

Regardo7epic Feb. 26 at 10:24 PM

$BINI with Jane Street being destroyed by $DJT and all of the momentum against the manipulating , high frequency spoofing investigations , depositions , and whistle blowers coming forward. These are very exciting days. $GNS $MMAT MMTLP $QNTM

1 · Reply

FickleFin Feb. 26 at 1:58 PM

$QNTM $GNS $GME 😒

0 · Reply

FickleFin Feb. 26 at 1:57 PM

$QNTM $GNS $GME

0 · Reply

Libre Feb. 24 at 8:19 PM

$BINI $MMAT $GNS $QNTM $GME All it is an order so sensitive information is not misused during discovery. You have no idea what you're talking about. It's a common order so that all parties in discovery don't disclose sensitive information to the public.

1 · Reply

Regardo7epic Feb. 24 at 4:46 PM

$BINI Great news guys !!! $MMAT Wes Christian & Kasowitz along with the receiver have filed a protective order Re the DTCC discovery !!!! This means that the DTCC was subpoenaed and sensitive trading / clearing trades /may be produced under seal. Spread sheets will tell the investigation a lot and this will help $BINI $GNS $QNTM MMTLP $GME and on and on. UBS ,Clear Street, IMS , Citadel,Virtu Anson Fund lawyers are frantically trying to come up with a ……. reason not to start a settlement contingency plan. IMO.

2 · Reply

FickleFin Feb. 24 at 12:47 PM

$QNTM $GNS $GME 📉↘️.... "Sometimes we want to believe something so badly that we allow ourselves to be taken advantage of."

0 · Reply

Redman70 Feb. 23 at 6:21 PM

$QNTM Just curious if anyone has tried contacting the company? Can you talk to them? Do they answer? What's their plan? Do they give updates on Unbuzzd? Do they give updates on their OWN version of the drink? Are they marketing it? What about the MS drug? Any lawsuit updates? Just curious if these guys are taking their fiduciary responsibilty to shareholders seriously. It sure doesn't look like it!! Awful. Stock was over $100 (split adjusted) a few years back. I wonder how this management team ranks if using stock performance as a benchmark.....probably one of the top 10 worst performances by a management team on the Nasdaq maybe over the last few years???? Just curious.

1 · Reply

FickleFin Feb. 23 at 2:25 PM

$QNTM No support. ATL is $2.70.

0 · Reply

FickleFin Feb. 23 at 12:41 PM

$QNTM $GNS $GME "Every decent con man knows that the simplest truth is more powerful than even the most elaborate lie." GAME OVER... 📉↘️

2 · Reply

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

Dec 10, 2025, 8:00 PM EST - 2 months ago

Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update

Nov 27, 2025, 4:00 PM EST - 3 months ago

Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC

Nov 26, 2025, 9:30 AM EST - 3 months ago

Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

Nov 7, 2025, 7:00 AM EST - 4 months ago

Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio

Oct 31, 2025, 7:51 PM EDT - 4 months ago

Quantum BioPharma Ltd. Provides Corporate Update

Oct 29, 2025, 9:00 PM EDT - 4 months ago

Quantum BioPharma Ltd. Announces Corporate Updates

Oct 23, 2025, 8:15 AM EDT - 4 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication

Oct 20, 2025, 8:30 AM EDT - 4 months ago

Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend

Oct 14, 2025, 8:15 AM EDT - 4 months ago

Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group

Oct 9, 2025, 6:00 PM EDT - 5 months ago

Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM

Oct 9, 2025, 5:40 PM EDT - 5 months ago

QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm

Oct 8, 2025, 8:00 AM EDT - 5 months ago

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Oct 7, 2025, 11:00 AM EDT - 5 months ago

Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View

Oct 3, 2025, 7:00 AM EDT - 5 months ago

Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case

Oct 2, 2025, 7:57 AM EDT - 5 months ago

Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial

Oct 1, 2025, 7:50 AM EDT - 5 months ago

Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials

Sep 29, 2025, 7:40 AM EDT - 5 months ago

Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders

Sep 26, 2025, 8:00 PM EDT - 5 months ago

Quantum BioPharma Announces Corporate Updates

Sep 24, 2025, 8:30 AM EDT - 5 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025

Sep 18, 2025, 8:10 AM EDT - 5 months ago

Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance

Sep 12, 2025, 7:50 AM EDT - 6 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT

Sep 10, 2025, 7:00 AM EDT - 6 months ago

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

Aug 11, 2025, 6:32 PM EDT - 7 months ago

Quantum BioPharma Announces Update to Previously Announced Private Placement

Aug 11, 2025, 7:40 AM EDT - 7 months ago

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

Aug 8, 2025, 8:00 AM EDT - 7 months ago

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

Aug 7, 2025, 7:00 AM EDT - 7 months ago

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt

Aug 5, 2025, 7:34 AM EDT - 7 months ago

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

Aug 4, 2025, 7:33 AM EDT - 7 months ago

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

Jul 31, 2025, 7:24 AM EDT - 7 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

Jul 30, 2025, 4:00 PM EDT - 7 months ago

Quantum BioPharma Shares' Rollercoaster Day: What's Going On?

Jul 22, 2025, 7:00 AM EDT - 7 months ago

Quantum BioPharma Makes Strategic Investment in GameStop Corp.

GME

Jun 27, 2025, 4:30 PM EDT - 8 months ago

Quantum BioPharma Announces Private Placement

Jun 26, 2025, 7:30 AM EDT - 8 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Jun 18, 2025, 9:19 AM EDT - 9 months ago

Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress

Jun 17, 2025, 8:00 AM EDT - 9 months ago

Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital

Jun 13, 2025, 7:00 AM EDT - 9 months ago

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

Jun 3, 2025, 7:50 AM EDT - 9 months ago

Quantum BioPharma Clarifies It Has Not Changed Its Name

Jun 2, 2025, 1:47 PM EDT - 9 months ago

iNGENū CRO Partners with Quantum BioPharma to Launch Pioneering Australian Clinical Trial for Chronic Nociplastic Pain in MCAS Patients

May 30, 2025, 7:00 AM EDT - 9 months ago

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

May 29, 2025, 7:30 AM EDT - 9 months ago

Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

May 28, 2025, 8:00 AM EDT - 9 months ago

Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 for Nociplastic Pain in Patients with Idiopathic Mast Cell Activation Syndrome

May 20, 2025, 7:30 AM EDT - 10 months ago

Quantum Biopharma Announces Signing of an Agreement with a Global Pharmaceutical Contract Research Organization to Prepare an IND (Investigational New Drug) Application Package for Lucid-21-302 (Lucid-MS), A First-In-Class Treatment for Multiple Sclerosis

May 19, 2025, 7:30 AM EDT - 10 months ago

Quantum Biopharma Purchases an Additional USD $1 Million of Bitcoin and Other Cryptocurrencies to Hold BTC Treasury and To Generate Staking Revenue. Bringing the Total Investment in Digital Assets to USD $4,500,000

May 16, 2025, 7:30 AM EDT - 10 months ago

Quantum BioPharma to Attend Sidoti Micro-Cap Investor Conference and the AGP Virtual Healthcare Conference

May 12, 2025, 8:00 AM EDT - 10 months ago

Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis

May 6, 2025, 8:25 PM EDT - 10 months ago

Quantum BioPharma Ltd. (QNTM) Business Update Conference Call Transcript

May 5, 2025, 7:08 AM EDT - 10 months ago

Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing

Apr 24, 2025, 7:00 AM EDT - 11 months ago

Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time

Apr 22, 2025, 7:00 AM EDT - 11 months ago

Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor

Regardo7epic Feb. 28 at 8:46 PM

1 · Reply

Regardo7epic Feb. 26 at 10:24 PM

1 · Reply

FickleFin Feb. 26 at 1:58 PM

$QNTM $GNS $GME 😒

0 · Reply

FickleFin Feb. 26 at 1:57 PM

$QNTM $GNS $GME

0 · Reply

Libre Feb. 24 at 8:19 PM

1 · Reply

Regardo7epic Feb. 24 at 4:46 PM

2 · Reply

FickleFin Feb. 24 at 12:47 PM

$QNTM $GNS $GME 📉↘️.... "Sometimes we want to believe something so badly that we allow ourselves to be taken advantage of."

0 · Reply

Redman70 Feb. 23 at 6:21 PM

1 · Reply

FickleFin Feb. 23 at 2:25 PM

$QNTM No support. ATL is $2.70.

0 · Reply

FickleFin Feb. 23 at 12:41 PM

$QNTM $GNS $GME "Every decent con man knows that the simplest truth is more powerful than even the most elaborate lie." GAME OVER... 📉↘️

2 · Reply

CryptoAlex1040 Feb. 22 at 9:47 PM

$GME $GNS $QNTM This is bullish. He’s a grifter

1 · Reply

FickleFin Feb. 22 at 8:01 PM

$QNTM $GNS $GME The con artist got conned... 😅 Retail got bagged. Game over.

0 · Reply

Regardo7epic Feb. 21 at 2:52 AM

$BINI Anson Funds lawyer hid behind the skirt of the cocaine snorting Citadel lawyer , the judge told him to collect himself. Hahhhah. Wes Christian smiled wide when the judge said to him “we are on the same page here “. 4 main things they are going to expose gentlemen. Spoofing Naked short selling Market makers who are not legal And my favorite!!!! Short and distort social media , and news outlets who prey on retail investors. $BINI $GNS $QNTM $GTII $MMAT MMTLP TRCH NBH. LETS GOOOOOO

2 · Reply

Fkubini2442 Feb. 21 at 1:35 AM

$BINI $GNS $QNTM

1 · Reply

Regardo7epic Feb. 21 at 1:16 AM

$BINI Tonight’s court hearing in MMAT receivership was AWSOME.. Wes Christian smoked Citadel, Anson Funds , and Virtu. The judge is leaning 100% towards a sealed discovery. $BINI FOLLOWS THIS SAME EXACT FRAME WORK!!! $GNS $QNTM MARKET FRAUD IS ABOUT TO BE EXPOSED ON ALL FRONTS.

2 · Reply

FickleFin Feb. 19 at 1:48 PM

$QNTM $GNS same sh!t different day... kevins back. 😒

1 · Reply

Regardo7epic Feb. 19 at 4:35 AM

$BINI If I was 98 years old and sat as the Impeccable Law maker, Judge Louis Stanton who put the stock manipulator Bernie Madoff behind bars , I would love to leave a legacy of putting these spoofing manipulators behind bars as well. I have a strong faith he will do what will help the simple family retail investor who has been abused for decades. Thank you Judge Stanton for your life of service in the legal framework of America. 👏👏👏 $BINI $MMAT MMTLP $GNS $QNTM NBH

3 · Reply

gloryb Feb. 18 at 4:16 PM

$QNTM wow crushing it today

0 · Reply

bounceamir Feb. 17 at 8:25 AM

$QNTM Pre-revenue quantum; speculative

0 · Reply

Kindah Feb. 17 at 12:13 AM

$QNTM fuck you kevin malone you scum bag piece of shit just for the record he hyped this POS for months claiming his “invesorts” are all in it, opening twitter space and playing on his father legacy! you’re so cheap man, enjoy your dirty money asshole, hope Karma does its thing ✌🏼

0 · Reply

StormSurgeX Feb. 16 at 11:20 PM

$QNTM $APPS $CPIX $INKT 0{}

0 · Reply

StormSurgeX Feb. 14 at 11:59 PM

$CAPT $QNTM $EVAX $IBO <>~>~>

0 · Reply

Market Cap	13.67M
Revenue (ttm)	0.00
Net Income (ttm)	-14.20M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	31,700
Avg Vol	69,090
Day's Range	N/A - N/A
Shares Out	3.82M
Stochastic %K	8%
Beta	0.30
Analysts	Sell
Price Target	$35.50